Fountainvest Partners
Asia gyms: Muscling through the mire
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
FountainVest backs China online ticketing player Maoyan
FountainVest Partners has acquired a significant minority stake in Maoyan Entertainment, a Chinese online ticketing business that completed an IPO in Hong Kong last February.
China PE: Tipping point?
Uncertainty continued to weigh on China private equity deal flow last year, leaving plenty of capital sitting on the sidelines waiting to reengage. GPs see diversification as an antidote to competition
Deal focus: EQT fulfills Laobaixing's prescription
EQT spent 11 years helping Chinese pharmacy chain Laobaixing evolve from large-format laggard into a focused and efficient operator that meets the needs of modern customers. It has now exited with a 7.7x return
FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
Investors cautiously optimistic on China buyouts - AVCJ Forum
The emergence of willing sellers, a pullback in competition from strategic investors, and greater availability of leveraged financing are contributing to more buyout deal flow in China.
China property marketplace trades flat after $78m IPO
Chinese online real estate marketplace Fangdd Network raised $78 million in its US IPO, having reduced the size of the offering, and traded flat on its first day on NASDAQ.
Chinese online property marketplace set for IPO
Fangdd Network, a Chinese online real estate marketplace backed by the likes of FountainVest Partners and CDH Investments, has filed to list in the US.
China ESG: Societal shift
China’s ESG compliance drive reflects a long structural change for financial markets and an evolutionary process for local business culture. Many investment variables are unique
Deal focus: Antengene targets unmet cancer problems
Chinese drug developer Antengene wins backing from the likes of Boyu Capital and FountainVest Partners for a pipeline of treatments that address the country's growing cancer problem
China’s Antengene raises $120m Series B round
Antengene Corporation, a Chinese biopharmaceutical company focused on oncology drugs and therapies, has raised $120 million in a Series B round led by Boyu Capital and FountainVest Partners.
CITIC Capital, FountainVest buy control of pallet leasing business
CITIC Capital Partners and FountainVest Partners have acquired a majority stake in China Merchants Loscam, a pallet and packaging business owned by Sinotrans, for RMB2.48 billion ($359 million).
FountainVest closes debut renminbi fund at $246.5m
FountainVest Partners, which has raised three US dollar-denominated China-focused funds, has closed its first renminbi vehicle at RMB1.7 billion ($246.5 million).
FountainVest-backed consortium makes tender offer for Amer
A consortium including FountainVest Partners and Chinese sportswear retailer Anta Sports has won board support for a EUR4.6 ($5.23 billion) tender offer for Finland-listed Amer Sports, which owns brands such as Salomon, Atomic, and Louisville Slugger.
GP-LP communication key to effective ESG policy – AVCJ Forum
Continued uptake of meaningful environmental, social, and governance (ESG) policies in private equity will depend on fostering deeper dialogue on the subject between GPs and LPs, according to industry participants at the AVCJ ESG Forum.
China-Europe: A sense of uncertainty
Chinese interest in European assets – from industrial technology to consumer brands – is undimmed, but certain governments, as well as the EU itself, are taking steps to protect their crown jewels
FountainVest pursues $5.3b European sports acquisition
A consortium including FountainVest Partners and Chinese athletics supplier Anta Sports have made a preliminary offer to acquire Finland-based Amer Sports for about EUR4.6 billion ($5.3 billion).
PE-backed Chinese healthtech firms to merge
China-based healthcare platforms Tencent Doctorworks and Xingren.com, both of which have several private equity and venture capital investors, have agreed to merge.
Yunfeng, Alibaba agree $1.4b iKang take-private
The protracted pursuit of Chinese healthcare services provider iKang Healthcare Group appears to have ended, with Yunfeng Capital and Alibaba Group agreeing to buy the business at a valuation of around $1.4 billion.
Tencent leads $818m round for China’s Chehaoduo
Chehaoduo, a Chinese online auto services provider that runs consumer-to-consumer (C2C) used car trading platform Guazi, has raised $818 million in a Series C round of funding led by Tencent Holdings.
FountainVest, OTPP back Hong Kong’s Pure Group
FountainVest Partners and Ontario Teachers’ Pension Plan (OTPP) have jointly invested in Hong Kong-headquartered fitness center and yoga studio operator The Pure Group.
ESG: Quantifiable benefits
Finding ways to implement environment, social and governance (ESG) policies and track performance with greater consistency has become a priority for some – but by no means all – Asian GPs
LPs demand integrated approach to ESG – AVCJ Forum
Private equity investors are focusing on policy implementation, team culture and transparency as environmental, social and governance (ESG) practices become an increasingly pervasive aspect of GP-LP negotiations.
FountainVest to buy German turbocharger business
China’s FountainVest Partners has agreed to acquire 100% of Bosch Mahle Turbo Systems (BMTS), a German automotive industry supplier with an existing production and sales presence in Shanghai.